Zobrazeno 1 - 10
of 293
pro vyhledávání: '"Mizolastine"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Nanomedicine, Vol Volume 16, Pp 7775-7799 (2021)
Ghada Ahmed El-Emam,1 Germeen NS Girgis,1 Mohammed Fawzy Hamed,2 Osama Abd El-Azeem Soliman,1 Abd El Gawad H Abd El Gawad1 1Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt; 2Department of Pathology, Facul
Externí odkaz:
https://doaj.org/article/804dfc1ef5b94be6a692d201b4d448f9
Autor:
Abd El Gawad H Abd El Gawad, Mohammed Fawzy Hamed, Osama A. Soliman, Germeen N S Girgis, Ghada Ahmed El-Emam
Publikováno v:
International Journal of Nanomedicine
Background Mizolastine (MZL) is a dual-action nonsedating topical antihistamine anti-inflammatory agent that is used to relieve allergic conditions, such as rhinitis and conjunctivitis. Solid lipid nanoparticles (SLNs) are advanced delivery system in
Publikováno v:
Archives of Dermatological Research. 311:801-805
The present study aimed to observe the therapeutic effect of combined mizolastine and proteoglycan in chronic urticaria. The patients were randomly divided into the treatment group (n = 56) and the control group (n = 44). The treatment group was medi
Publikováno v:
Journal of Molecular Graphics & Modelling
A novel strain of coronavirus, namely, SARS-CoV-2 identified in Wuhan city of China in December 2019, continues to spread at a rapid rate worldwide. There are no specific therapies available and investigations regarding the treatment of this disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d15a3c3026250cda209e9dc54b2c31b
https://doi.org/10.26434/chemrxiv.12318689
https://doi.org/10.26434/chemrxiv.12318689
Autor:
Sheng-Ju Yin, Min-Ji Wei, Pu Li, Ya-Qing Lou, Xuan Wei, Zi-Sheng Kang, Suo-Di Zhai, Xin Wang, Yuan Lu, Zhi-Yuan Zhang, Guo-Liang Zhang
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 123:464-473
Mizolastine is a selective histamine H1 receptor antagonist for chronic urticaria or allergic rhinitis. We investigated whether the variant genotypes of metabolic enzymes UGT1A1, CYP3A5 and transporter ABCB1 influence pharmacokinetic phenotype of sub
Publikováno v:
Allergologie Select
Background: H1 antihistamines are important drugs for the treatment of urticaria and are commonly well tolerated. Cases of hypersensitivity reactions to antihistamines have rarely been reported, the underlying pathomechanism is unknown yet. Case repo
Autor:
Hitender Kumar, Amandeep Singh
Publikováno v:
International Journal of Basic and Clinical Pharmacology. :1228-1233
Background: Second-generation antihistamines (SGAs) are the most commonly used drugs for AR nowadays. The cost of medicines is very important determinant in drug compliance; selection of low cost quality drugs would thus be helpful in improving compl
Autor:
Wei Zhang, Juan Su, Jie Li, Mingliang Chen, Cong Peng, Fangfang Li, Xiang Chen, Siyu Yan, Wu Zhu, Qingling Li, Zhao-Qian Liu, Wangqing Chen, Jianglin Zhang
Publikováno v:
Experimental dermatology. 28(3)
Chronic spontaneous urticaria (CSU) is a frequent disorder with recurrent itchy wheals and/or angioedema, and nearly 35% patients respond poorly to non-sedating H1 antihistamine treatment. CRP gene encodes the C-reactive protein, which is involved in
Publikováno v:
Journal of Clinical & Cellular Immunology.
Objective: This study investigated total glucosides of paeony (TGP)'s effect on serum IL-17 and IL-25 concentrations in patients with chronic autoimmune urticaria (CAU).Methods: 71 autologous serum skin test (ASST)+CAU patients were randomized into t